ID: ALA5289787

Max Phase: Preclinical

Molecular Formula: C22H28N4O10

Molecular Weight: 508.48

Associated Items:

Representations

Canonical SMILES:  C[C@@H]([C@H](N)C(=O)N[C@H](C(=O)O)[C@@H]1C[C@@H](O)[C@@H](O)[C@H](n2ccc(=O)[nH]c2=O)O1)[C@H](O)c1ccc(O)cc1

Standard InChI:  InChI=1S/C22H28N4O10/c1-9(17(30)10-2-4-11(27)5-3-10)15(23)19(32)25-16(21(33)34)13-8-12(28)18(31)20(36-13)26-7-6-14(29)24-22(26)35/h2-7,9,12-13,15-18,20,27-28,30-31H,8,23H2,1H3,(H,25,32)(H,33,34)(H,24,29,35)/t9-,12+,13-,15-,16-,17-,18+,20+/m0/s1

Standard InChI Key:  VSIBSKJVEGOXHC-SQLXPRKWSA-N

Associated Targets(non-human)

Aspergillus niger 16508 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Candida albicans 78123 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cryptococcus neoformans 21258 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Coccidioides immitis 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 508.48Molecular Weight (Monoisotopic): 508.1805AlogP: -2.48#Rotatable Bonds: 8
Polar Surface Area: 237.43Molecular Species: ACIDHBA: 11HBD: 8
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.48CX Basic pKa: 7.95CX LogP: -4.60CX LogD: -4.70
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.19Np Likeness Score: 1.05

References

1. Serpi M, Ferrari V, Pertusati F..  (2016)  Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?,  59  (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325]

Source